Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bone Marker Feedback Impact on Ibandronate Adherence
NCT00545909Phase 4Completed
- Sponsor
- Roche
- Start
- Mar 2006
- Primary completion
- Aug 2008
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 4 trial of ibandronate in postmenopausal osteoporosis, sponsored by Roche. Started Mar 2006; status: completed.
02
Drugs
ibandronate
03
Conditions
postmenopausal osteoporosis
Beyond the preview
Go deeper on NCT00545909.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00545909.